mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0008 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0008 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.002 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |